BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 6402519)

  • 1. Differentiation between spores of Bacillus anthracis and Bacillus cereus by a quantitative immunofluorescence technique.
    Phillips AP; Martin KL; Broster MG
    J Clin Microbiol; 1983 Jan; 17(1):41-7. PubMed ID: 6402519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of spore surface antigens in the genus Bacillus by the use of polyclonal antibodies in immunofluorescence tests.
    Phillips AP; Martin KL
    J Appl Bacteriol; 1988 Jan; 64(1):47-55. PubMed ID: 3127370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of Bacillus anthracis by polyclonal antibodies against extracted vegetative cell antigens.
    Phillips AP; Ezzell JW
    J Appl Bacteriol; 1989 May; 66(5):419-32. PubMed ID: 2502530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative immunofluorescence studies of the serology of Bacillus anthracis spores.
    Phillips AP; Martin KL
    Appl Environ Microbiol; 1983 Dec; 46(6):1430-2. PubMed ID: 6419678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of a microfluorometer in immunofluorescence assays of individual spores of Bacillus anthracis and Bacillus cereus.
    Phillips AP; Martin KL
    J Immunol Methods; 1982 Mar; 49(3):271-82. PubMed ID: 6802901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secondary cell wall polysaccharides of Bacillus anthracis are antigens that contain specific epitopes which cross-react with three pathogenic Bacillus cereus strains that caused severe disease, and other epitopes common to all the Bacillus cereus strains tested.
    Leoff C; Saile E; Rauvolfova J; Quinn CP; Hoffmaster AR; Zhong W; Mehta AS; Boons GJ; Carlson RW; Kannenberg EL
    Glycobiology; 2009 Jun; 19(6):665-73. PubMed ID: 19270075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significant passive protective effect against anthrax by antibody to Bacillus anthracis inactivated spores that lack two virulence plasmids.
    Enkhtuya J; Kawamoto K; Kobayashi Y; Uchida I; Rana N; Makino SI
    Microbiology (Reading); 2006 Oct; 152(Pt 10):3103-3110. PubMed ID: 17005989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunization of mice with formalin-inactivated spores from avirulent Bacillus cereus strains provides significant protection from challenge with Bacillus anthracis Ames.
    Vergis JM; Cote CK; Bozue J; Alem F; Ventura CL; Welkos SL; O'Brien AD
    Clin Vaccine Immunol; 2013 Jan; 20(1):56-65. PubMed ID: 23114705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteomic profiling and identification of immunodominant spore antigens of Bacillus anthracis, Bacillus cereus, and Bacillus thuringiensis.
    Delvecchio VG; Connolly JP; Alefantis TG; Walz A; Quan MA; Patra G; Ashton JM; Whittington JT; Chafin RD; Liang X; Grewal P; Khan AS; Mujer CV
    Appl Environ Microbiol; 2006 Sep; 72(9):6355-63. PubMed ID: 16957262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of Bacillus anthracis spore component antigens conserved across diverse Bacillus cereus sensu lato strains.
    Mukhopadhyay S; Akmal A; Stewart AC; Hsia RC; Read TD
    Mol Cell Proteomics; 2009 Jun; 8(6):1174-91. PubMed ID: 19208616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of a fluorescent-antibody procedure for identifying Bacillus cereus in foods.
    Kim HU; Goepfert JM
    Appl Microbiol; 1972 Nov; 24(5):708-13. PubMed ID: 4629698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of immunofluorescence measurements of individual bacteria in direct and indirect assays for Bacillus anthracis and Bacillus cereus spores.
    Phillips AP; Martin KL
    J Appl Bacteriol; 1982 Oct; 53(2):223-31. PubMed ID: 6819288
    [No Abstract]   [Full Text] [Related]  

  • 13. Saccharides cross-reactive with Bacillus anthracis spore glycoprotein as an anthrax vaccine component.
    Kubler-Kielb J; Vinogradov E; Hu H; Leppla SH; Robbins JB; Schneerson R
    Proc Natl Acad Sci U S A; 2008 Jun; 105(25):8709-12. PubMed ID: 18562275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variations on the staining method in quantitative indirect immunofluorescence assays for Bacillus spores, and the use of fluorescein--protein A.
    Phillips AP; Martin KL
    J Immunol Methods; 1982 Nov; 54(3):361-9. PubMed ID: 6184416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunofluorescence analysis of bacillus spores and vegetative cells by flow cytometry.
    Phillips AP; Martin KL
    Cytometry; 1983 Sep; 4(2):123-31. PubMed ID: 6414791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of antibodies against anthrose tetrasaccharide for specific detection of Bacillus anthracis spores.
    Kuehn A; Kovác P; Saksena R; Bannert N; Klee SR; Ranisch H; Grunow R
    Clin Vaccine Immunol; 2009 Dec; 16(12):1728-37. PubMed ID: 19793896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of direct and indirect immunoradiometric assays (IRMA) for Bacillus anthracis spores immobilised on multispot microscope slides.
    Phillips AP; Martin KL
    J Appl Bacteriol; 1983 Oct; 55(2):315-24. PubMed ID: 6418708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoclonal antibodies against spore antigens of Bacillus anthracis.
    Phillips AP; Campbell AM; Quinn R
    FEMS Microbiol Immunol; 1988 Dec; 1(3):169-78. PubMed ID: 2483677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual-parameter scatter-flow immunofluorescence analysis of Bacillus spores.
    Phillips AP; Martin KL
    Cytometry; 1985 Mar; 6(2):124-9. PubMed ID: 3884295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Of spore opsonization and passive protection against anthrax.
    Goossens PL; Sylvestre P; Mock M
    Microbiology (Reading); 2007 Feb; 153(Pt 2):301-2; discussion 302-4. PubMed ID: 17259600
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.